The Split Skinny on MLNM and LTR
Why are you not looking at MLNM, which is splitting on 4/19, or
LTR Loews Corp. for a post split run? Any comments regarding
these two?
Well, the reason we are not looking at Millennium Pharmaceuticals
(MLNM) is because it's trading at $29.88, a slight discount to
its 52-week high of $89.81. What's more, MLNM isn't slated to
split its stock on 4/19. In fact, its last split was on April
18, 2000 when its stock was fetching $114.88 a share. In all
honesty, we don't consider MLNM to be a split candidate at
current levels.
As for LTR, we did follow that stock on our Current Play list for
two weeks on early March. What's more, we posted a nice 6
percent gain during that period. LTR began trading split
adjusted on March 21, so its split run is over.
